These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 33427019

  • 1. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
    Descoeur J, Dupuy AM, Bargnoux AS, Cristol JP, Mathieu O.
    J Oncol Pharm Pract; 2022 Jan; 28(1):55-63. PubMed ID: 33427019
    [Abstract] [Full Text] [Related]

  • 2. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
    Günther V, Mueller D, von Eckardstein A, Saleh L.
    Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
    Aumente MD, López-Santamaría J, Donoso-Rengifo MC, Reyes-Torres I, Montejano Hervás P.
    Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay:  Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
    Bouquié R, Grégoire M, Hernando H, Azoulay C, Dailly E, Monteil-Ganière C, Pineau A, Deslandes G, Jolliet P.
    Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of methotrexate and 7-hydroxymethotrexate by liquid chromatography for routine monitoring of plasma levels.
    Cociglio M, Hillaire-Buys D, Alric C.
    J Chromatogr B Biomed Appl; 1995 Dec 01; 674(1):101-10. PubMed ID: 8749257
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of a new high-performance liquid chromatography method with fluorescence polarization immunoassay for analysis of methotrexate.
    Najjar TA, Matar KM, Alfawaz IM.
    Ther Drug Monit; 1992 Apr 01; 14(2):142-6. PubMed ID: 1585400
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid.
    Castoldi S, Cozzi V, Baldelli S, Fucile S, Clementi E, Cattaneo D.
    Ther Drug Monit; 2018 Feb 01; 40(1):140-143. PubMed ID: 29324625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
    Borgman MP, Hiemer MF, Molinelli AR, Ritchie JC, Jortani SA.
    Ther Drug Monit; 2012 Apr 01; 34(2):193-7. PubMed ID: 22377747
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole.
    Peña-Lorenzo D, Rebollo N, Sánchez-Hernández JG, Zarzuelo-Castañeda A.
    Ann Clin Biochem; 2021 Nov 01; 58(6):657-660. PubMed ID: 34482744
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of time to clearance of high-dose methotrexate using the ARK immunoassay in pediatric hematology/oncology patients: A single-center experience.
    Kowalski KE, Higgins TA.
    Pediatr Blood Cancer; 2021 Mar 01; 68(3):e28788. PubMed ID: 33164288
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.